Vital Therapies Appoints Chicago LTx Expert to BOD

[Guest guest]

Vital Therapies, Inc. announced today that J.

Millis, M.D., has been appointed to the company's Board of Directors. Dr. Millis is professor of Surgery and chief, Section of

Transplantation at the University of Chicago Hospitals. As

an expert in adult and pediatric transplant surgery, he has performed more

liver transplants than any other surgeon in the region.

The ELAD® system provides important metabolic

support for patients with severe liver failure, thereby enabling a bridge to

recovery or transplant depending on the type and severity of liver disease. The system consists of four cartridges containing cells

that function like a normal human liver by metabolizing toxins and removing

waste products while delivering essential proteins back into the plasma. These cartridges are incorporated into a blood pumping

system at the patient's bedside and enable continuous patient treatment for up

to 12 days. The key to the performance of ELAD is its

utilization of a proprietary human hepatocyte cell

line, C3A, an immortalized cell line that can be grown, stored and shipped

worldwide…….

http://biz.yahoo.com/prnews/070129/sfm106.html?.v=65